Triveni Bio
The Director, Business Development at Triveni Bio will lead the company’s external innovation and partnering strategy, identifying, evaluating, negotiating, and closing in‑licensing, out‑licensing, collaboration, and partnership deals to expand the pipeline. Reporting to the COO, the role involves sourcing opportunities in immunology and inflammation, conducting scientific and commercial assessments, building financial models, and coordinating cross‑functional diligence and execution.
Triveni Bio is a clinical-stage biotechnology company taking a genetics-informed approach and leveraging advanced antibody engineering to develop first-in-class therapeutics for immune and inflammatory (I&I) diseases. The company's pipeline includes bispecific antibodies such as TRIV-573 and TRIV-509, targeting conditions like atopic dermatitis. Triveni's approach is rooted in human genetics and novel biology, aiming to redefine treatment paradigms for patients with uncontrolled inflammatory disease.
Triveni Doses First Subject in Global Phase 2 Proof of Concept Study of TRIV-509 in Atopic Dermatitis, Presents Translational Data at 2025 EADV Congress Demonstrating Novel Biology in Patient Samples
Sep 23, 2025
Triveni Bio Doses First Healthy Volunteers in Clinical Trial for TRIV-509, Coinciding with Preclinical Data Presentations Further Validating Novel Kallikrein 5/7 Biology in Atopic Dermatitis
May 21, 2025
Wilson Sonsini Advises Goldman Sachs Alternatives on Patent Matters Related to Series B Investment in Triveni Bio
Oct 18, 2024
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Triveni Bio.
24% above the average for this role
Director, Search and Evaluation, BD&L Pacific Innov Hub
MSD
Equity Research Associate – Emerging Immunology
Leerink Partners
Director, Business Development & Licensing – Oncology Search and Evaluation, Europe Hub
MSD
Ventures Associate Director in Immunology and Inflammation
Schrödinger
Executive Director, Corporate Development
Travere Therapeutics
Associate Director, Search and Evaluation
Travere Therapeutics